EGF受容体に結合する成長因子における負の協力性の構造的基礎
Diego Alvarado1, Daryl E Klein, Mark A Lemmon
1Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6059, USA.
Cell
|August 21, 2010
まとめ
Epidermal Growth Factor Receptor (EGFR) の結合は負の協力性を示し,最初のリガンド結合は,その後の結合に対する親和性を減少させる. これは,細胞表面のEGF受容体特性と,異なるシグナル伝達特性を説明します.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 細胞シグナル伝達 細胞信号伝達
背景:
- エピデルマ・成長因子受容体 (EGFR) 経由のトランスメブラン信号伝達は,細胞の成長と分化に極めて重要です.
- EGFRのシグナル伝達には,その細胞内チロシンキナーゼ領域のリガンド誘発型二分化とアロステリック調節が含まれます.
- 以前の結晶学研究では細胞外二分化が説明されていたが,観察された高親和低親和のEGF結合部位は説明されなかった.
研究 の 目的:
- 細胞表面のEGF受容体結合で観察された曲ったScatchardプロットの構造的基礎を解明する.
- EGFの結合部位の高親和と低親和の現象を説明するために.
- EGFRに負の協力性リガンド結合のメカニズムを理解する.
主な方法:
- ドロソフィラEGFR細胞外領域の一連の結晶構造の分析.
- リガンド誘発の二分化と初期リガンド結合後の構造変化を調査する.
- 非対称ディマー形成の構造分析と,その後のリガンド親和性への影響.
主要な成果:
- Scatchard plot の曲線が,負の協力性のあるリガンド結合から生じることを示した.
- 最初のリガンド結合が1つの結合リガンドを持つ非対称ディマーを誘導することを示した.
- 非対称二重体内の空き結合部位が構造的に抑制され,第2リガンドに対する親和性が低下していることが確認されました.
結論:
- この研究では, EGF受容体の細胞表面結合特性を説明し,カーブしたScatchardプロットを含む.
- 負の協同性は,初期リガンド結合後に形成される非対称二元体の構造的制約から生じる.
- 研究結果は,異なるEGFRリガンドが,異なるシグナリング結果を持つ異なる二次元種を安定させることを示唆しています.
関連する概念動画
Enzyme-linked Receptors
64.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.7K
Allosteric Regulation
53.3K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
53.3K
Cooperative Allosteric Transitions
7.4K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.4K
Cooperative Binding of Transcription Regulators
6.0K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.0K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
The Two-State Receptor Model
3.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.5K


